Wird geladen...
Ambrisentan: a review of its use in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a progressive disease defined by an elevation in pulmonary arterial pressure that can lead to right heart failure and death. Ambrisentan is a selective endothelin receptor antagonist approved for the treatment of idiopathic, heritable PAH and connective tissu...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Respir Dis |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933647/ https://ncbi.nlm.nih.gov/pubmed/28425346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465817696040 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|